Front. Mol. Neurosci. Frontiers in Molecular Neuroscience Front. Mol. Neurosci. 1662-5099 Frontiers Media S.A. 10.3389/fnmol.2016.00154 Neuroscience Correction Corrigendum: Better Targeting, Better Efficiency for Wide-Scale Neuronal Transduction with the Synapsin Promoter and AAV-PHP.B Jackson Kasey L. 1 Dayton Robert D. 1 Deverman Benjamin E. 2 Klein Ronald L. 1 * 1Department of Pharmacology, Toxicology, and Neuroscience, Louisiana State University Health Sciences Center Shreveport, LA, USA 2Division of Biology and Biological Engineering, California Institute of Technology Pasadena, CA, USA

Edited and reviewed by: Andrew Paul Tosolini, University College London, UK

*Correspondence: Ronald L. Klein klein@lsuhsc.edu

 22 12 2016 2016 9 154 29 11 2016 07 12 2016 Copyright © 2016 Jackson, Dayton, Deverman and Klein. 2016 Jackson, Dayton, Deverman and Klein

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A corrigendum on Better Targeting, Better Efficiency for Wide-Scale Neuronal Transduction with the Synapsin Promoter and AAV-PHP.B by Jackson, K. L., Dayton, R. D., Deverman, B. E., Klein, R. L. (2016). Front. Mol. Neurosci. 9:116. doi: 10.3389/fnmol.2016.00116 adeno-associated virus amyotrophic lateral sclerosis gene therapy gene transfer promoter synapsin promoter targeting TDP-43 Amyotrophic Lateral Sclerosis Association10.13039/100000971 Karyopharm Therapeutics10.13039/100007136 Hereditary Disease Foundation10.13039/100001671

The following acknowledgments were missing from the original article.

BD was supported by the Hereditary Disease Foundation, the Beckman Institute and the Resource Center for CLARITY, Optogenetics and Vector Engineering, which supports technology development and dissemination at the California Institute of Technology. The AAV-PHP.B plasmid was distributed from the Gradinaru Laboratory at the California Institute of Technology. The authors thank Viviana Gradinaru for her help in providing the AAV-PHP.B plasmid.

The authors apologize for this mistake. This error does not in any way change the scientific conclusions of the article.

Conflict of interest statement

BED is listed as an inventor on a patent application related to AAV-PHP.B. KLJ, RDD and RLK have no conflicts of interest to disclose.